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Background:
Heterogeneity in recombinant protein quality (e.g. glyco-
sylation) can result from a) changes in cultivation condi-
tions during a fermentation process, b) product
degradation due to differing residence times of product
molecules in the supernatant, c) heterogeneities in intra-
cellular PTM (post transcriptional modification)
machinery, or from a combination thereof. To minimize
heterogeneity in product quality it is of importance to
evaluate the impact of these different mechanisms.
Therefore we developed and applied a protocol, which
can be used for analysis of a spectrum of different
recombinant proteins and production cell lines aiming
to provide a tool that enables growth phase related pro-
duct analytics, for monitoring variations of the product
during different phases of a cultivation process. Impor-
tant for growth phase specific product analysis is the
possibility to separate recombinant proteins produced
during different growth phases. Exchanging media with-
out changing its composition regarding nutrient and
waste products should result in growth characteristics
comparable to a cultivation without media exchange.
Materials and methods:
An erythropoietin-producing CHO K1-derived cell line
was cultivated in parallel with the host cell line in batch
culture in chemically defined, animal component-free
CHO growth media (Xell AG) for different cultivation per-
iods. Furthermore the a-1-antitrypsin producing human
AGE1.hn cell clone was cultivated simultaneously. At
defined time points a media exchange was performed by
replacing the supernatant of the production cell line,
which contained the product, with supernatant of the host
cell line. The supernatant of the production cell line was
stored at - 20 °C for later analysis. Afterwards cultivation
was continued until viability dropped below 50 %. Addi-
tionally, a control batch of the production cell line was
performed without media exchange. All batches were car-
ried out at least in two biological replicates. Cultivations
with and without media exchange were compared in
terms of to viable cell density and viability (CEDEX
(Roche)), glucose and lactate levels (YSI (Xylem)) as well
as amino acid concentrations (HPLC). Secreted recombi-
nant erythropoietin from different fermentation phases
was analyzed by capillary zone electrophorese (CZE,
Kontron Instruments) to get an insight of the degree of
sialylation, as crucial modification for product quality.
Results
During the cultivation of CHO-K1-EPO and its host cell
line, we could observe, that the production cell line
reached higher cell densities (up to 156 × 105 cells/mL)
than the host cell line (83 × 105 cells/mL) (Fig. 1 (A)).
Therefore substrate concentrations like glucose and glu-
tamine decreased earlier than during the cultivation of
the host cell line (Fig. 1 (C), (E)).
On the contrary the cultivation of AGE1.hn and
AGE1.hn-AAT ran much more similar (Fig. 1 (B)).
Glucose, lactate (Fig. 1 (D)) and the amino acid data
(Fig. 1 (F)) show similar trends comparing the host cell
line with the production cell line the production cell
line with and without media exchange.
In Fig. 1 (B) the results of a CZE of recombinant ery-
thropoietin produced in different phases are shown. We
detected nine isoforms due to different degrees of sialy-
lation of the N- and O-glycans, as described for recom-
binant erythropoietin before [1]. In a later fermentation* Correspondence: klaudia.grunwald@uni-bielefeld.de
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phase little effects on sialylation (isoforms seven, eight
and nine)are obvious. At day nine of the cultivation the
viability decreased from 90 % to under 80 %, and on day
ten the viability was below 50 %. Sialylases accumulating
in the supernatant due to cell lysis, may be responsible
for the decline of product quality by reducing the
amount of sialic acids [2,3].
Conclusions
Fermentation phase specific sampling with media
exchanges at similar cell densities shows no changes neither
in growth behavior nor glucose, lactate and amino acid
metabolism. For this procedure it is important, that the
nutrient content of the conditioned media is similar to the
media to be exchanged. For a production cell line which
growth behavior differs highly from the host cell line the
cultivation needs to be adapted, or supernatants from dif-
ferent fermentation phases have to be prepared in advance
for proper utilization at time of medium exchange.
Differential analysis of product heterogeneity relating
to different fermentation phases is possible without any
labeling of substrates, Glycosylation (N-glycans, O-gly-
cans), degree of sialylation or the ratio of isoforms, all of
high importance for product quality, can be analyzed
easily in this way.
In this case, most of the product heterogeneity of ery-
thropoietin produced by CHO-K1-EPO seems to be
based on the cell itself. Apparently only few variations
are due to different residence times.
In addition to this fermentation phase dependent sam-
pling, the impact of different residence times on products
in media as well as in supernatants needs to be analyzed
to gain a deeper insight into reasons for product heteroge-
neity. With these handy experiments factors for variable
product heterogeneity can be identified for every product
and cell line to optimize the cell, the media and the
process.
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Figure 1 Viable cell densities and viability of batch cultivations of (A) CHO-K1-EPO and CHO-K1 (B) AGE1.hn-AAT and AGE1.hn; Glucose
and lactate concentration of batch cultivations of (C) CHO-K1-EPO and CHO-K1 (D) AGE1.hn-AAT and AGE1.hn; Amino acid course of (E) CHO-
K1-EPO and CHO-K1 (F) AGE1.hn-AAT and AGE1.hn batch cultivations: aspartate (-), asparagine (···), glutamine ( - -), glutamate(– –); (G) Percentage
of the nine most common isoforms of erythropoietin produced during different fermentation phases.
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